Matrubials develops milk-inspired therapeutics to fight antimicrobial resistance. Our first indication is bacterial vaginosis, with future focus on topical applications.
Matrubials Inc. is developing novel antibacterial therapeutics to address non-selectivity and emerging antimicrobial resistance.
Our mission is to provide safe solutions that can reduce the healthcare and economic burden resulting from bacterial infections and concomitant clinical complications.
Matrubials' therapeutics target all genders and ages impacted by bacterial infections.